IXCHIQ chikungunya vaccine withdrawn in UK after safety review
MHRA withdraws IXCHIQ’s UK licence after safety review found benefits no longer outweighed risks, including rare neurological events and deaths.
Pathogens, stewardship and the response to emerging threats.
Pathogens, stewardship and the response to emerging threats.